The level of plasma renin activity in patients with combination of chronic obstructive pulmonary disease and arterial hypertension
Abstract
Chronic obstructive pulmonary disease (COPD) is often combined with hypertension (AH). One of the common factors in the development of this pathology is the activation of the renin-angiotensin-aldosterone system. Plasma renin activity in patients with combination of COPD and AH and patients with AH; in patients in groups with a combination of COPD and AH, separated by structural changes in lung tissue and patients with AH was studied.
About the Authors
E. L. Selezneva
ФГБОУ ВО УГМУ МЗ РФ
Russian Federation
Russian Federation
T. V. Zhdanova
ФГБОУ ВО УГМУ МЗ РФ
Russian Federation
Russian Federation
L. A. Maslova
ФГБОУ ВО УГМУ МЗ РФ
Russian Federation
Russian Federation
E. V. Kuznetsova
ФГБОУ ВО УГМУ МЗ РФ
Russian Federation
Russian Federation
References
1. Кароли Н. А., Ребров А. П. Предикторы риска смерти пациентов с ХОБЛ // Пульмонология. 2007; 3: 77–80.
2. Кароли Н. А., Орлова Е. Е., Маркова А. В. Коморбидность при хронической обструктивной болезни легких // Терапевтичнский архив. 2008; 3: 20–23.
3. Egan B. M., Zhao Y., Axon R. N. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008 // J. Am. Med. Assoc. 2010; 303 (20): 2043–2050.
4. Laragh J. H., Sealey J. E. The plasma renin test reveals the contribution of body sodium-volume content (V) and reninangiotensin (R) vasoconstriction to long-term blood pressure // Am. J. Hypertens. 2011; 24 (11): 1164–1180.
5. Centers for Disease Control and Prevention. Vital signs: prevalence, treatment, and control of hypertension — United States, 1999–2002 and 2005–2008 // MMWR Morb. Mortal Weekly Rep. 2011; 60 (4):103–108.
6. Sealey J. E., Alderman M. H., Furberg C. D., Laragh J. H. Renin-angiotensin system blockers may create more risk than reward for sodium depleted cardiovascular patients with high plasma renin levels // Am. J. Hypertens. 2013; 26: 727–738.
7. Sidney S., Sorel M., Quessenberry C. P. Jr. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program // Chest. 2005; 128: 2068–2075.
8. Forth R., Montgomery H. ACE in COPD: a therapeutic target? // Thorax. 2003; 58: 556–558.
9. Mascitelli L., Pezzetta F., Tkacova R., Joppa P. Inhibition of the Renin-Angiotensin System in Patients With COPD and Pulmonary Hypertension // Chest. 2007; 131 (3): 938–939.
10. Ishani A., Weinhandl E., Zhao Z. J. et al. Angiotensin-converting-enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction // Am. Coll. Cardiol. 2005; 45: 391–399.
11. Ратова Л. Г., Зыков К. А., Долгушева Ю. А. Артериальная гипертония и бронхообструктивная патология — особенности клинической картины // Системные гипертензии. 2012; 1: 54–58.
12. Высоцкий А. Г. Буллезная эмфизема легких: этиология, патогенез, классификация // Новости медицины и фармации // Аллергология, пульмонология и иммунология. 2008: 265–267.
Review
For citations:
Selezneva E.L., Zhdanova T.V., Maslova L.A., Kuznetsova E.V. The level of plasma renin activity in patients with combination of chronic obstructive pulmonary disease and arterial hypertension. Lechaschi Vrach. 2018;(10):35. (In Russ.)
Views:
234
JATS XML
Email this article 
